Abstract:Accurately predicting drug sensitivity and understanding what is driving it are major challenges in drug discovery. Graphs are a natural framework for capturing diverse pharmacological data for efficacy predictions, thanks to their ability to integrate multimodal data and represent relationships such as gene-gene or drug-target interactions as edges. They have also had proven success across a range of other drug discovery tasks including repositioning and target identification. In this study, we sought to address the explainability challenges of drug response predictions. Recent developments in the field of Graph AI have led to improvements in interpretability mechanisms that highlight parts of a graph which are driving predictions. We have conducted a comprehensive review of multiple major approaches for tackling drug efficacy prediction using graph methods, benchmarking the performance and interpretability of these algorithms across indications. Methods: We assembled a combined dataset of GDSC1 and GDSC2 drug response data in cell lines, with multiomic cell line data and drug target and chemical structure data. We then applied graph-based approaches for the prediction of binarized IC50 on an indication-by-indication basis. Approach 1 involved the creation of a 'GDSC knowledge graph', where drug response and cell line 'omic information is represented in an unweighted knowledge graph: cell lines are connected to genes expressed in them, drugs are connected to genes they target, and so on. We then used state-of-the-art graph embedding techniques to predict IC50 using paired drug and cell line embeddings. In Approach 2 we used a weighted knowledge graph instead, and generated embeddings using heterogeneous graph neural networks (HGNNs). In Approach 3, we modelled response prediction as a graph classification task, where one single graph captures one drug-cell line interaction. The graph classifier and HGNN models both have in-built interpretability mechanisms, including graph attention, that can signify the genes in the cell line which were most important for the eventual prediction. We can also integrate biomedical prior knowledge with all these models by capturing gene-pathway and gene-gene data in the graphs. Results: Our models outperformed benchmark models including DNNs and GBMs, and identified both established and novel response biomarkers in NSCLC cell lines (AUC = 0.94, Accuracy = 89%). We have also applied our models to Breast Cancer, Pancreatic Cancer, Colorectal Cancer and Haematological malignancies with similar predictive performance and explainability. Conclusions:Our graph analytical framework for response predictions showed better performance than benchmarking models and provided insights from explainability. This framework is easily extendable to response and 'omic data from any disease model and patient studies. Citation Format: Jake Cohen-Setton, Krishna Bulusu, Jonathan Dry, Ben Sidders. Explainable AI: Graph machine learning for response prediction and biomarker discovery [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 902.

Explaining decisions of graph convolutional neural networks: patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer

Explainable Multilayer Graph Neural Network for Cancer Gene Prediction

Graph neural networks learn emergent tissue properties from spatial molecular profiles

Digital Histopathology with Graph Neural Networks: Concepts and Explanations for Clinicians

xCG: Explainable Cell Graphs for Survival Prediction in Non-Small Cell Lung Cancer

Stable feature selection utilizing Graph Convolutional Neural Network and Layer-wise Relevance Propagation for biomarker discovery in breast cancer

Multi-layered Knowledge Graph Neural Network Reveals Pathway-level Agreement of Three Breast Cancer Multi-gene Assays

An Explainable Classification Method Based on Complex Scaling in Histopathology Images for Lung and Colon Cancer

Graph deep learning for the characterization of tumour microenvironments from spatial protein profiles in tissue specimens

Single-cell gene regulatory network prediction by explainable AI

Pan-Cancer Metastasis Prediction Based on Graph Deep Learning Method

Lymph Node Graph Neural Networks for Cancer Metastasis Prediction

Unveiling Molecular Moieties through Hierarchical Graph Explainability

Abstract 902: Explainable AI: Graph machine learning for response prediction and biomarker discovery

Path-based reasoning in biomedical knowledge graphs

Spatially Aware Graph Neural Networks and Cross-Level Molecular Profile Prediction in Colon Cancer Histopathology: a Retrospective Multi-Cohort Study.

Bi-level Graph Learning Unveils Prognosis-Relevant Tumor Microenvironment Patterns in Breast Multiplexed Digital Pathology

PathoGraph: An Attention-Based Graph Neural Network Capable of Prognostication Based on CD276 Labelling of Malignant Glioma Cells

GNN-SubNet: disease subnetwork detection with explainable Graph Neural Networks

Explainable convolutional neural networks for assessing head and neck cancer histopathology

Spatial Omics Driven Crossmodal Pretraining Applied to Graph-based Deep Learning for Cancer Pathology Analysis